Both in Pharmaceuticals
Aardvark Therapeutics vs Celularity
Over the past year AARD returned −88.2% and CELU returned −52.5%; their daily moves had a correlation of 0.14.
AARD −88.2% CELU −52.5%Growth of $1, one year, split-adjusted
| Metric | AARD | CELU |
|---|---|---|
| Price | $1.23 | $0.8171 |
| Market cap | $26.9M | $26.5M |
| Today | +2.50% | +1.82% |
| 1 month | −76.4% | −52.2% |
| 6 months | −77.5% | −14.3% |
| Year to date | −90.6% | −26.4% |
| 1 year | −88.5% | −58.1% |
| Revenue growth (YoY) | — | −5.3% |
| Gross margin | — | 56.8% |
| Net margin | — | 10.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 1.4× |
| Net cash | $73.9M | -$37.1M |
| Dividend yield | — | — |
| Volatility (60d) | 240.8% | 223.1% |
| Short % of float | 4.6% | 6.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).